Literature DB >> 19337822

Gastric emptying of pellets under fasting conditions: a mathematical model.

Igor Locatelli1, Ales Mrhar, Marija Bogataj.   

Abstract

PURPOSE: To develop a mathematical model that would adequately describe human gastric emptying of pellets under fasting conditions of healthy subjects.
METHODS: Scintigraphic profiles representing the gastric emptying of pellets were obtained from the literature. Altogether 19 individual and three mean scintigraphic profiles were collected. Three mathematical models namely; the lag-time exponential (two parameters), the Weibull (two parameters), and the double Weibull (five parameters) model were proposed and fitted to the gastric emptying profiles.
RESULTS: Different patterns of gastric emptying (immediate and rapid, delayed but rapid, delayed and slow, and interruptive emptying) were observed, with the emptying time varied from approximately 15 min to more than 3 h. The best model for fitting to the individual profiles was the double Weibull model. This model also provided an insight into the mechanism of interruptive emptying of pellets, observed for some patients. In addition, mean gastric emptying of pellets was calculated using the Weibull model.
CONCLUSIONS: Mean gastric emptying of pellets was adequately described by the Weibull model (eta = 61.9 min, beta = 0.895), which could be applied in the design of in vitro dissolution experiments for pellet formulations with pH dependent dissolution.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19337822     DOI: 10.1007/s11095-009-9869-3

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  21 in total

Review 1.  The role of gamma-scintigraphy in oral drug delivery.

Authors:  I R Wilding; A J Coupe; S S Davis
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

2.  Gastrointestinal spread of oral prolonged-release mesalazine microgranules (Pentasa) dosed as either tablets or sachet.

Authors:  I R Wilding; C J Kenyon; G Hooper
Journal:  Aliment Pharmacol Ther       Date:  2000-02       Impact factor: 8.171

Review 3.  Gamma scintigraphy in the evaluation of pharmaceutical dosage forms.

Authors:  S S Davis; J G Hardy; S P Newman; I R Wilding
Journal:  Eur J Nucl Med       Date:  1992

4.  Gastrointestinal transit of model mini-tablet controlled release oral dosage forms in fasted human volunteers.

Authors:  F Podczeck; N Course; J M Newton; M B Short
Journal:  J Pharm Pharmacol       Date:  2007-07       Impact factor: 3.765

5.  Transit of pharmaceutical dosage forms through the small intestine.

Authors:  S S Davis; J G Hardy; J W Fara
Journal:  Gut       Date:  1986-08       Impact factor: 23.059

6.  The use of gamma scintigraphy to follow the gastrointestinal transit of pharmaceutical formulations.

Authors:  F N Christensen; S S Davis; J G Hardy; M J Taylor; D R Whalley; C G Wilson
Journal:  J Pharm Pharmacol       Date:  1985-02       Impact factor: 3.765

7.  The description of the gastrointestinal transit of pellets assessed by gamma scintigraphy using statistical moments.

Authors:  F Podczeck; J M Newton; K H Yuen
Journal:  Pharm Res       Date:  1995-03       Impact factor: 4.200

8.  Validity of the geometric mean correction in the quantification of whole bowel transit.

Authors:  J G Hardy; A C Perkins
Journal:  Nucl Med Commun       Date:  1985-04       Impact factor: 1.690

9.  Combined scintigraphic and pharmacokinetic investigation of enteric-coated mesalazine micropellets in healthy subjects.

Authors:  I R Wilding; C Behrens; S J Tardif; H Wray; P Bias; W Albrecht
Journal:  Aliment Pharmacol Ther       Date:  2003-05-01       Impact factor: 8.171

10.  Gastrointestinal transit and release of 5-aminosalicylic acid from 153Sm-labelled mesalazine pellets vs. tablets in male healthy volunteers.

Authors:  M Brunner; R Greinwald; K Kletter; H Kvaternik; M E Corrado; H G Eichler; M Müller
Journal:  Aliment Pharmacol Ther       Date:  2003-05-01       Impact factor: 8.171

View more
  7 in total

1.  Vagus nerve stimulation promotes gastric emptying by increasing pyloric opening measured with magnetic resonance imaging.

Authors:  K-H Lu; J Cao; S Oleson; M P Ward; R J Phillips; T L Powley; Z Liu
Journal:  Neurogastroenterol Motil       Date:  2018-05-24       Impact factor: 3.598

2.  A Simple, Realistic Stochastic Model of Gastric Emptying.

Authors:  Jiraphat Yokrattanasak; Andrea De Gaetano; Simona Panunzi; Pairote Satiracoo; Wayne M Lawton; Yongwimon Lenbury
Journal:  PLoS One       Date:  2016-04-08       Impact factor: 3.240

Review 3.  Ghrelin, CCK, GLP-1, and PYY(3-36): Secretory Controls and Physiological Roles in Eating and Glycemia in Health, Obesity, and After RYGB.

Authors:  Robert E Steinert; Christine Feinle-Bisset; Lori Asarian; Michael Horowitz; Christoph Beglinger; Nori Geary
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 4.  The Use of Physiologically Based Pharmacokinetic Analyses-in Biopharmaceutics Applications -Regulatory and Industry Perspectives.

Authors:  Om Anand; Xavier J H Pepin; Vidula Kolhatkar; Paul Seo
Journal:  Pharm Res       Date:  2022-05-18       Impact factor: 4.580

5.  A quantitative model for metabolic intervention using gut microbes.

Authors:  Zachary J S Mays; Nikhil U Nair
Journal:  Biotechnol Prog       Date:  2021-01-16

6.  Does age affect gastric emptying time? A model-based meta-analysis of data from premature neonates through to adults.

Authors:  Jennifer J Bonner; Pavan Vajjah; Khaled Abduljalil; Masoud Jamei; Amin Rostami-Hodjegan; Geoffrey T Tucker; Trevor N Johnson
Journal:  Biopharm Drug Dispos       Date:  2015-02-12       Impact factor: 1.627

7.  A Mechanistic Physiologically-Based Biopharmaceutics Modeling (PBBM) Approach to Assess the In Vivo Performance of an Orally Administered Drug Product: From IVIVC to IVIVP.

Authors:  Marival Bermejo; Bart Hens; Joseph Dickens; Deanna Mudie; Paulo Paixão; Yasuhiro Tsume; Kerby Shedden; Gordon L Amidon
Journal:  Pharmaceutics       Date:  2020-01-17       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.